Thomas Michael Moriarty
AdvisorMr. Thomas Michael Moriarty, also known as Tom, J.D., served as Executive Vice President of M&A and Corporate Affairs since March 2025 until November 18, 2026 and will remain as Advisor until February 27, 2027 at Albertsons Companies, Inc. and served as General Counsel at Albertsons Companies, Inc. since June 05, 2023 until March 2025. He was Chief Policy Officer at Albertsons Companies, Inc. since June 2023 until March 2025. He had been Chief Policy and External Affairs Officer at CVS Health Corporation since March 2, 2017 until February 13, 2023 and had been its Executive Vice President and General Counsel since October 2012 until February 13, 2023. He served as Chief Strategy Officer at CVS Health Corporation from March 2014 to March 2, 2017. Mr. Moriarty served as Chief Health Care Strategy Officer at CVS Health Corporation since March 2014. He served as General Counsel and Corporate Secretary at Celgene Corporation from May 07, 2012 to November 26, 2012. He joined Celgene from Medco Health Solutions where he directed all legal, regulatory, public policy and corporate governance functions. He served as President of Global Pharmaceutical Strategies of Medco Health Solutions, Inc. since March 2011 and as its General Counsel and Secretary since March 2008. Mr. Moriarty served as Senior Vice President of Pharmaceutical Strategies & Solutions of Medco Health Solutions Inc. from September 2007 to March 2011. He served as Senior Vice President of Business Development at Medco Health Solutions, Inc., since August 2006. Other positions held within Medco include Deputy General Counsel, Vice President & Managing Counsel, where he was responsible for mergers and acquisitions and client and commercial contracting from December 2005 to August 2006 for the Commercial Transerves as actions group. He joined Medco in June 2000 as an Assistant Counsel. Prior to joining Medco, he held several leadership positions in the biopharmaceutical industry including Assistant General Counsel, Pharma & North America for Merial Limited, a Merck & Co. and Aventis Company. He served as General Counsel, Senior Attorney and Assistant Counsel for Merck & Co., Inc. He joined Merck in 1993. From November 2002 to December 2005, Mr. Moriarty served as Vice President and Counsel of Client Contracting. He began his career at the law firm of Mudge Rose Guthrie Alexander and Ferdon in New York. He received his JD degree from the University of Virginia School of Law in 1989 and bachelor's degree in Government and Law from Lafayette College in 1985.
Positions
- Company NameAlbertsons Companies, Inc.Stock CodeACIPositionAdvisorColleagues
- SDSusan D. MorrisCEO & Director
- MCMargaret Cushing WhitmanExecutive Chairman of the Board
- ADAnuj DhandaExecutive VP and Chief Technology & Transformation Officer
- JSJennifer SaenzExecutive VP & Chief Commercial Officer
- SLSharon L. McCollamSenior Advisor
- RGRobert G. MillerChairman Emeritus
- SRScott R. WilleDirector
- SLSharon L. AllenIndependent Director
